ATE4316T1 - Organische sulfoxide mit einer latenten allylgruppe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische antibakterielle zusammensetzung. - Google Patents

Organische sulfoxide mit einer latenten allylgruppe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische antibakterielle zusammensetzung.

Info

Publication number
ATE4316T1
ATE4316T1 AT80104803T AT80104803T ATE4316T1 AT E4316 T1 ATE4316 T1 AT E4316T1 AT 80104803 T AT80104803 T AT 80104803T AT 80104803 T AT80104803 T AT 80104803T AT E4316 T1 ATE4316 T1 AT E4316T1
Authority
AT
Austria
Prior art keywords
latent
production
composition containing
antibacterial composition
organic sulfoxides
Prior art date
Application number
AT80104803T
Other languages
English (en)
Inventor
Raymond A. Firestone
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE4316T1 publication Critical patent/ATE4316T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Polymerisation Methods In General (AREA)
AT80104803T 1979-08-15 1980-08-14 Organische sulfoxide mit einer latenten allylgruppe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische antibakterielle zusammensetzung. ATE4316T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6660379A 1979-08-15 1979-08-15
EP80104803A EP0025857B1 (de) 1979-08-15 1980-08-14 Organische Sulfoxide mit einer latenten Allylgruppe, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische antibakterielle Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE4316T1 true ATE4316T1 (de) 1983-08-15

Family

ID=22070551

Family Applications (4)

Application Number Title Priority Date Filing Date
AT80104802T ATE5403T1 (de) 1979-08-15 1980-08-14 Organische sulfoxide, verfahren zu deren herstellung und diese enthaltende pharmazeutische enzym-blockierende zusammensetzungen.
AT80104803T ATE4316T1 (de) 1979-08-15 1980-08-14 Organische sulfoxide mit einer latenten allylgruppe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische antibakterielle zusammensetzung.
AT80104806T ATE3545T1 (de) 1979-08-15 1980-08-14 Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym hemmende pharmazeutische zusammensetzung, die sie enthaelt.
AT80104805T ATE7785T1 (de) 1979-08-15 1980-08-14 Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym- hemmende pharmazeutische zusammensetzung, die sie enthaelt.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT80104802T ATE5403T1 (de) 1979-08-15 1980-08-14 Organische sulfoxide, verfahren zu deren herstellung und diese enthaltende pharmazeutische enzym-blockierende zusammensetzungen.

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT80104806T ATE3545T1 (de) 1979-08-15 1980-08-14 Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym hemmende pharmazeutische zusammensetzung, die sie enthaelt.
AT80104805T ATE7785T1 (de) 1979-08-15 1980-08-14 Organische sulphoxyde mit einer latenten allylgruppe, verfahren zu deren herstellung und enzym- hemmende pharmazeutische zusammensetzung, die sie enthaelt.

Country Status (9)

Country Link
EP (4) EP0025857B1 (de)
JP (4) JPS5630961A (de)
AT (4) ATE5403T1 (de)
DE (4) DE3063503D1 (de)
DK (4) DK350980A (de)
ES (4) ES494304A0 (de)
GR (4) GR69805B (de)
IE (4) IE50152B1 (de)
PT (4) PT71652B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
US4553191A (en) * 1982-12-03 1985-11-12 Xerox Corporation Static eliminator
EP0123543B1 (de) * 1983-04-21 1988-02-03 Merck Frosst Canada Inc. Leukotrienantagonisten, deren Herstellung und Verwendung sowie diese enthaltende Zusammensetzungen
US4609744A (en) * 1983-04-21 1986-09-02 Merck Frosst Canada Inc. 4-oxo-benzopyran carboxylic acids
FR2661909B1 (fr) * 1990-05-09 1997-08-14 Inst Nat Sante Rech Med Nouveaux composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation.
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
JP2003513065A (ja) * 1999-10-29 2003-04-08 ザ・ピコワー・インスティチュート・フォー・メディカル・リサーチ Ｍｉｆアンタゴニスト活性を有する化合物
EP2209474A4 (de) 2007-10-09 2013-07-24 Sopharmia Inc Breitband-beta-lactamase-hemmer
WO2014165126A2 (en) 2013-03-12 2014-10-09 Sopharmia, Inc. Derivatized 3-styryl-cephalosporins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3419606A (en) * 1964-05-13 1968-12-31 Merck & Co Inc 4-(2-methylenealkanoyl)phenylsulfinyl alkanoic acids
CH496639A (fr) * 1968-01-05 1970-09-30 Pfizer & Co C Procédé de préparation des aryl halogénocarbonyl cétènes
CH568708A5 (de) * 1969-04-30 1975-11-14 Hoffmann La Roche
DE2147610A1 (de) * 1970-09-25 1972-06-08 Shell Internationale Research Maat schappij N V , Den Haag (Niederlande) 2,6 Dimtro aniline
GB1463077A (en) * 1973-04-19 1977-02-02 Glaxo Lab Ltd 7-substituted-ethyl-cephalosporin derivatives
US4049806A (en) * 1975-08-15 1977-09-20 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
JPS5253890A (en) * 1975-10-14 1977-04-30 Syntex Inc Production of cephalosporin type compound
US4155907A (en) * 1976-08-16 1979-05-22 The Dow Chemical Company Method for inhibiting ADP-induced platelet aggregation using phenylthioalkylamines
JPS5350326A (en) * 1976-10-18 1978-05-08 Kao Corp Herbicides
AU4091178A (en) * 1977-10-25 1980-04-24 Merck & Co Inc Substituted mercapto acid amides

Also Published As

Publication number Publication date
IE50152B1 (en) 1986-02-19
DK351080A (da) 1981-02-16
GR69834B (de) 1982-07-19
DK350980A (da) 1981-02-16
IE801705L (en) 1981-02-15
ES494305A0 (es) 1981-08-01
ES8106284A1 (es) 1981-08-01
ATE5403T1 (de) 1983-12-15
ATE3545T1 (de) 1983-06-15
EP0025857B1 (de) 1983-07-27
GR69832B (de) 1982-07-19
DE3065684D1 (en) 1983-12-29
EP0024347A1 (de) 1981-03-04
EP0025857A1 (de) 1981-04-01
GR69805B (de) 1982-07-12
PT71654B (en) 1982-01-22
IE801707L (en) 1981-02-15
DK351180A (da) 1981-02-16
IE50225B1 (en) 1986-03-05
JPS5663989A (en) 1981-05-30
JPS5643260A (en) 1981-04-21
EP0026307B1 (de) 1983-11-23
GR69833B (de) 1982-07-19
ES8106285A1 (es) 1981-08-01
EP0026307A1 (de) 1981-04-08
PT71653B (en) 1982-01-21
IE50151B1 (en) 1986-02-19
IE801706L (en) 1981-02-15
IE50150B1 (en) 1986-02-19
PT71652B (en) 1982-01-21
PT71652A (en) 1980-09-01
PT71651A (en) 1980-09-01
PT71654A (en) 1980-09-01
ES494304A0 (es) 1981-08-01
DE3063503D1 (en) 1983-07-07
DE3064411D1 (en) 1983-09-01
JPS5630960A (en) 1981-03-28
ES8106282A1 (es) 1981-08-01
JPS5630961A (en) 1981-03-28
DE3068110D1 (en) 1984-07-12
DK351280A (da) 1981-02-16
ATE7785T1 (de) 1984-06-15
PT71651B (en) 1982-01-21
ES494303A0 (es) 1981-08-01
EP0024639B1 (de) 1984-06-06
EP0024347B1 (de) 1983-05-25
EP0024639A1 (de) 1981-03-11
IE801708L (en) 1981-02-15
ES8106283A1 (es) 1981-08-01
PT71653A (en) 1980-09-01
ES494302A0 (es) 1981-08-01

Similar Documents

Publication Publication Date Title
PT91602A (pt) Processo para a preparacao de compostos espiro com accao antibacteriana e de composicoes farmaceuticas que os contem
FI940806A0 (fi) Sykliset johdokset, näitä yhdisteitä sisältävät lääkeaineet ja menetelmä niiden valmistamiseksi
ATE4316T1 (de) Organische sulfoxide mit einer latenten allylgruppe, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische antibakterielle zusammensetzung.
FR2551062B1 (fr) Polyphenols a liaisons en ortho, leur application en tant que stabilisants de matieres organiques, et compositions stabilisees renfermant de tels polyphenols
ATE38838T1 (de) Verfahren und zwischenprodukte zur herstellung von penem-derivaten.
SE8206923D0 (sv) Azolyl-penten-derivat, forfarande for framstellning av dessa foreningar samt biocida medel innehallande dem
BR8100539A (pt) Derivados de benzoxazolona,composicao fungicida ou bactericida contendo os mesmos,processo para sua preparacao bem como sua aplicacao
ATE16186T1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung.
SE8105628L (sv) Cefalosporinderivat
BR8806379A (pt) Processo para a preparacao de compostos e composicao fungicida
ATE4202T1 (de) Verfahren zur herstellung von pyrrol-2essigs[ureestern.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee